LEI DE PROPRIEDADE INDUSTRIAL: PARÁGRAFO ÚNICO DO ARTIGO 40 DA LEI 9.279/96 E ACESSO A MEDICAMENTOS GENÉRICOS
DOI:
https://doi.org/10.21527/2176-6622.2019.52.115-124Keywords:
Generic medicine; Patent; Industrial Property; Intellectual Property; Patent Extension.Abstract
The research aims to analyze the effects of the application of the single paragraph from article 40 of the Industrial Property Law, which provides the possibility of extending the validity of the patent regarding the access to generic medicines. It presents a view about the protection of the intellectual property as a fundamental right. It also verifies the situation of the analysis of patent applications process, under the responsibility of the National Institute of Industrial Property (INPI), as a way of understanding what led the legislator to introduce the aforementioned paragraph in article 40 of the Industrial Property Law, especially regarding generic medicines. The method used is the deductive, based on legislation bibliographical revision, doctrine and jurisprudence. It is concluded that the single paragraph of the article 40 of the Industrial Property Law, which aimed to minimize the damages of inventors in the face of the delays in the processing of patent applications by INPI, which should only occur in exceptional cases, is systematically applied because of the backlog, delaying the entry of new generic medicines in the market and, consequently, preventing more people from accessing generic medicines, which are generally cheaper, safer and more effective than traditional medicines.
Downloads
Published
How to Cite
Issue
Section
License
By publishing in the Revista Direito em Debate, authors agree to the following terms:
Articles are licensed under the Creative Commons Atribuição 4.0 Internacional (CC BY 4.0), which allows:
Share — copy and redistribute the material in any medium or format;
Adapt — remix, transform, and build upon the material for any purpose, including commercial use.
These permissions are irrevocable, provided the following terms are respected:
Attribution — authors must be properly credited, with a link to the license and indication of any modifications made;
No additional restrictions — no legal or technological measures may be applied that restrict the use permitted by the license.
Notices:
The license does not apply to elements in the public domain or covered by legal exceptions.
The license does not grant all rights required for specific uses (e.g., image rights, privacy, or moral rights).
The journal is not responsible for opinions expressed in the articles, which remain the sole responsibility of the authors. The Editor, with the support of the Editorial Committee, reserves the right to suggest or request modifications when necessary.
Only original scientific articles presenting research results of interest, not previously published or simultaneously submitted to another journal with the same purpose, will be accepted.
References to trademarks or specific products are intended solely for identification purposes and do not imply any promotional endorsement by the authors or the journal.
License Agreement (for articles published as of 2026): Authors retain copyright over their articles and grant the Revista Direito em Debate the right of first publication.
